Semaglutide FAQ: Plain Answers to the Most-Asked Questions
How does semaglutide work?
Semaglutide copies GLP-1, a gut hormone that signals fullness and boosts insulin. In rodents it reached the brainstem, area postrema, and hypothalamic arcuate nucleus, cutting food intake and shifting food preference without lowering energy expenditure [4]. It also improves glucose-dependent insulin release and slows gastric emptying [12]. The weight effect is central: people eat less because the brain asks for less.
How long does it take for semaglutide to suppress appetite?
Many people in patient communities describe appetite and "food noise" quieting within the first week or two, though this is anecdotal rather than a measured trial endpoint. Mechanistically, semaglutide acts on brain appetite circuits and reaches steady blood levels because its half-life is about one week [4][13]. The studied dose is also raised slowly over weeks, so the full effect builds over time.
Why does semaglutide make you tired?
Tiredness is commonly reported by users, especially in the first day or two after a dose and during early weeks, and it usually eases with time — but this is an anecdotal pattern, not a defined trial finding. It often tracks with eating much less and with not drinking enough fluid. In trials, the dominant adverse effects are gastrointestinal rather than fatigue [5].
How does semaglutide reduce appetite in the brain?
It reaches appetite-control regions directly. In rodents, semaglutide accessed the brainstem, area postrema, arcuate nucleus, and parabrachial nucleus, reducing intake without lowering energy expenditure [4]. Inside the arcuate nucleus it activates "full" POMC/CART neurons and inhibits "hungry" NPY/AgRP neurons [8]; this brain region is required for GLP-1-agonist weight loss [9].
What is semaglutide?
Semaglutide is a 31-amino-acid peptide that copies about 94% of human GLP-1, the gut hormone that curbs appetite and boosts insulin [4]. Engineered to resist breakdown and bind albumin, it lasts about a week per dose [13]. It is FDA-approved for type 2 diabetes, chronic weight management, cardiovascular risk reduction, and (2025) the fatty-liver disease MASH.
What is semaglutide used for?
Semaglutide is approved for type 2 diabetes, long-term weight management, lowering the risk of major cardiovascular events in adults with established heart disease and overweight or obesity, and (2025) metabolic dysfunction-associated steatohepatitis (MASH). In STEP 1 it produced a mean weight change of -14.9% at 68 weeks versus -2.4% on placebo [1], and in SELECT it cut cardiovascular events by 20% [3].
How does semaglutide work for weight loss?
It quiets appetite at the source. In rodents it reached brain appetite circuits and cut food intake without lowering energy expenditure, so weight falls because eating drops, not because metabolism speeds up [4]. In STEP 1, once-weekly 2.4 mg produced a mean body-weight change of -14.9% at 68 weeks versus -2.4% on placebo [1].
What is the semaglutide dosage for weight loss?
As documented in trials and labeling, the subcutaneous weight-management dose is raised gradually: 0.25 mg weekly for weeks 1-4, then 0.5, 1.0, 1.7, and 2.4 mg maintenance. STEP 1 studied the 2.4 mg dose, producing a mean -14.9% weight change at 68 weeks [1]. This is study-attributed information, not dosing advice; dosing decisions belong to a prescriber.
How many mg is 40 units of semaglutide?
"Units" are an insulin-syringe measure and do not map to a manufacturer-defined semaglutide dose; semaglutide is dosed in milligrams (for example 0.25-2.4 mg subcutaneous), and unit-based conversions are a known source of dosing error. A pharmaceutical-sciences review describes semaglutide's mg-based dosing across its formulations [11]. Any conversion is a clinical matter, not something this digest advises.
What is compounded semaglutide?
Compounded semaglutide is prepared by a compounding pharmacy rather than as the approved, manufactured product. It was permitted during a federally declared shortage from roughly 2022 into early 2025, then curtailed once the shortage resolved. The approved-product trial evidence — SUSTAIN-6 and the others [2] — was generated with the manufactured drug, so compounded sources fall outside that evidence base.
What are the side effects of semaglutide?
The dominant side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation — usually mild-to-moderate and concentrated around dose increases [5][14]. A safety review reports nausea in roughly one-third of patients and notes increased gallstone risk, with pancreatic and thyroid signals unconfirmed [5]. In SUSTAIN-6, retinopathy complications rose in those with pre-existing eye disease undergoing rapid sugar correction [2].
How long does it take for semaglutide to work?
It depends on the effect. The studied dose is raised over weeks, and steady drug levels build because the half-life is about one week [13]. Appetite effects are often described early in patient reports (anecdotal), while the weight result measured in STEP 1 was the change at 68 weeks (-14.9% vs -2.4% on placebo) [1].
How long does semaglutide stay in your system?
Semaglutide's elimination half-life is approximately one week (commonly cited as about 165-168 hours), so it takes roughly five weeks to clear after the last dose [13]. That long tail comes from strong albumin binding and DPP-4 resistance, and it is why label guidance advises stopping well before a planned pregnancy [13].
What is the half-life of semaglutide?
About one week — commonly cited as roughly 165-168 hours — for both the injection and the oral tablet, with effectively complete clearance about five weeks after the final dose [13]. This long half-life is engineered through albumin binding via the C18 fatty di-acid side chain plus DPP-4 resistance from the Aib-8 substitution [13].
Is oral semaglutide as effective as the injection?
They are the same molecule by different routes. The oral tablet has very low oral availability (~0.4-1%) and must be taken fasted with little water, which is why higher milligram doses are used orally [22]. A pharmaceutical-sciences review summarizes both once-daily and once-weekly options; comparative magnitude depends on dose and formulation rather than the molecule changing [11].
Why am I not losing weight on semaglutide?
Trial results are averages, and individual responses vary widely. STEP 1 reported a mean change of -14.9% at 68 weeks, which includes a range of responses [1]; the studied dose is also raised gradually over months, so effects build over time. Lean-mass changes and plateaus are documented [17]. Why an individual responds a given way is a clinical question, not one this digest can answer.
Does semaglutide make you tired?
Fatigue is commonly reported by users, especially right after a dose and in early weeks, usually easing with time — an anecdotal pattern rather than a defined trial endpoint. It often coincides with eating much less and with dehydration. The adverse effects established in trials are predominantly gastrointestinal [5].
Is semaglutide a GLP-1?
Yes — semaglutide is a GLP-1 receptor agonist, a long-acting analogue of the gut hormone glucagon-like peptide-1, sharing about 94% of its structure [4]. By switching on GLP-1 receptors it boosts glucose-dependent insulin, suppresses glucagon, slows gastric emptying, and acts on brain appetite circuits [12]. SUSTAIN-6 is one of its landmark GLP-1-class outcome trials [2].
Does semaglutide cause hair loss?
Hair shedding appears as a pharmacovigilance reporting signal with semaglutide and tirzepatide [20], but the pattern fits telogen effluvium — a reversible, diffuse shedding linked to the magnitude and rate of weight loss — rather than direct drug toxicity [21]. People generally describe it as temporary. It is not established as a direct effect of the drug itself.
How fast does semaglutide work?
Blood levels build over the early weeks because the half-life is about one week, and the studied dose is raised step by step [13]. Appetite changes are often reported early by users (anecdotal), while the formal weight outcome in STEP 1 was measured at 68 weeks (-14.9% vs -2.4% on placebo) [1]. "Fast" depends on which effect you mean.
What is the difference between semaglutide and tirzepatide?
Tirzepatide is a dual agonist (GIP and GLP-1 receptors); semaglutide targets GLP-1 alone. In the SURMOUNT-5 head-to-head trial of 751 adults with obesity, tirzepatide produced greater mean weight loss at 72 weeks (-20.2% vs -13.7%; P<0.001) [7]. Semaglutide carries the larger cardiovascular- and kidney-outcomes evidence base to date [3][6].
What is the downside of semaglutide?
The main downsides are gastrointestinal side effects (nausea, vomiting, diarrhea, constipation), concentrated at dose increases [5][14], plus increased gallstone risk and a class warning for pancreatitis [5]. Weight regain after stopping is substantial — about 11.6 percentage points within a year in the STEP 1 extension [18] — and a share of weight lost is lean mass [17].